Volume 588; Issue 16

FEBS Letters

Volume 588; Issue 16
1

p53: The barrier to cancer stem cell formation

Year:
2014
Language:
english
File:
PDF, 940 KB
english, 2014
4

PML tumour suppression and beyond: Therapeutic implications

Year:
2014
Language:
english
File:
PDF, 823 KB
english, 2014
5

The cytoplasmic side of p53’s oncosuppressive activities

Year:
2014
Language:
english
File:
PDF, 1.69 MB
english, 2014
6

Deregulation of cell signaling in cancer

Year:
2014
Language:
english
File:
PDF, 780 KB
english, 2014
8

Mutant p53 reactivation by small molecules makes its way to the clinic

Year:
2014
Language:
english
File:
PDF, 479 KB
english, 2014
9

Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy

Year:
2014
Language:
english
File:
PDF, 758 KB
english, 2014
10

Keep-ING balance: Tumor suppression by epigenetic regulation

Year:
2014
Language:
english
File:
PDF, 2.17 MB
english, 2014
11

Molecular insights into NF2/Merlin tumor suppressor function

Year:
2014
Language:
english
File:
PDF, 1.10 MB
english, 2014
13

p53 and ribosome biogenesis stress: The essentials

Year:
2014
Language:
english
File:
PDF, 734 KB
english, 2014
14

The multifaceted von Hippel–Lindau tumour suppressor protein

Year:
2014
Language:
english
File:
PDF, 870 KB
english, 2014
16

Wild type p53 reactivation: From lab bench to clinic

Year:
2014
Language:
english
File:
PDF, 1.20 MB
english, 2014
17

Tumor suppression

Year:
2014
Language:
english
File:
PDF, 214 KB
english, 2014
18

The Angiomotins – From discovery to function

Year:
2014
Language:
english
File:
PDF, 933 KB
english, 2014
22

Editorial Board

Year:
2014
Language:
english
File:
PDF, 29 KB
english, 2014